Quick Answer
Inogen Inc reported Cash and Equivalents of $103.73 million for fiscal year 2025.
Inogen Inc Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $103.73M | -8.8% |
| 2024 | $113.80M | -9.3% |
| 2023 | $125.49M | -32.9% |
| 2022 | $187.01M | -20.6% |
| 2021 | $235.52M | +11.1% |
| 2020 | $211.96M | +7.0% |
| 2019 | $198.04M | +0.7% |
| 2018 | $196.63M | +37.6% |
| 2017 | $142.95M | +54.0% |
| 2016 | $92.85M | +40.5% |
| 2015 | $66.11M | +16.3% |
| 2014 | $56.84M | +320.4% |
| 2013 | $13.52M | -10.5% |
| 2012 | $15.11M | +286.9% |
| 2011 | $3.91M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $106.48M | +0.7% | +2.7% |
| June 30, 2025 | $103.69M | +5.9% | -12.8% |
| March 31, 2025 | $118.89M | +10.7% | +4.5% |
| December 31, 2024 | $113.80M | -9.3% | +7.7% |
| September 30, 2024 | $105.69M | -15.2% | +7.9% |
| June 30, 2024 | $97.92M | -41.6% | -8.9% |
| March 31, 2024 | $107.44M | -34.5% | -14.4% |
| December 31, 2023 | $125.49M | -32.9% | +0.7% |
- Inogen Inc showed a decrease of -8.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2011–2025 period, Inogen Inc’s cash and equivalents has grown by 2555.6% (from $3.91 million to $103.73 million).
- The most recent figure is from Inogen Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: